Related Experiment Video
Updated: Aug 15, 2026

06:08
Quantification of Hypopigmentation Activity In Vitro
Published on: March 6, 2019
Human Insulin Enhances Avobenzone Photostability while Retaining Its Biological Activity
Deepak Kumar Sahoo1, Sachin Mallikarjun More1, Pooja Dhurjad2
1Department of Chemistry, School of Chemical Sciences, Central University of Karnataka, Kalaburagi, Karnataka 585367, India.
ACS Omega
|August 14, 2026
Summary
Human insulin enhances the stability of avobenzone, a common UVA filter, protecting it from UV light degradation. This insulin-avobenzone complex maintains insulin
Area of Science:
- Photochemistry
- Biophysics
- Dermatology
Background:
- Avobenzone (AVB), a key UVA filter in sunscreens, degrades under UV exposure, reducing its effectiveness.
- Human insulin, relevant in diabetes therapy and dermatology, was explored for its potential to stabilize AVB.
- Understanding AVB photodegradation is crucial for developing more effective photoprotective formulations.
Purpose of the Study:
- To investigate the interaction between human insulin and avobenzone (AVB).
- To evaluate the impact of insulin on AVB photostability and binding.
- To assess the preservation of insulin's biological activity upon complexation with AVB.
Main Methods:
- UV spectroscopy for photodegradation studies.
- Electrospray ionization-tandem mass spectrometry (ESI-MS/MS) for complex identification.
- Fluorescence spectroscopy and 19F Nuclear Magnetic Resonance (NMR) for binding analysis.
- Molecular dynamics (MD) simulations for interaction mechanism elucidation.
Main Results:
- Insulin significantly enhanced AVB photostability under simulated sunlight and UV irradiation.
- A noncovalent insulin-AVB complex formed, with up to three AVB molecules binding per insulin.
- Binding affinity was determined (52.1 μM), with interactions involving hydrogen bonding and AVB tautomer stabilization.
- Insulin's biological activity was preserved in the insulin-AVB complex.
Conclusions:
- Human insulin acts as a photoprotective agent for avobenzone, enhancing its stability.
- The insulin-avobenzone complex formation stabilizes AVB without compromising insulin bioactivity.
- This finding offers a potential strategy for improving sunscreen efficacy and managing diabetes-related skin issues.
Related Concept Videos
Insulin: Biosynthesis, Chemistry, and Preparation
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Insulin Formulations: Types and Delivery
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Short-acting insulins are divided into rapid-acting...
Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Cross-reactivity
Overview